Moreover, we found that SLC22A8 expression was significantly different in different cancer stages, race, gender, age, tumor grade, and nodal metastasis status (Fig. S3, Supplemental Digital Content, http://links.lww.com/MD/H122). Here, SLC22A8 is linked to cancer.